Hidronefrosis
Published on August 21, 2026
Risk Factors
Older males (BPH), nephrolithiasis, pregnancy, pelvic/abdominal malignancy, neurogenic bladder, congenital anomalies (UPJ obstruction in neonates), chronic anticholinergic use
Etiology
Obstruction of urinary outflow at any point from the renal pelvis to the urethral meatus, resulting in retrograde pressure and collecting system dilation
Presentation
Flank pain (colicky or dull), decreased urine output or anuria (bilateral obstruction), hematuria, recurrent UTIs; may be entirely asymptomatic and found incidentally
Classic Exam
CVA tenderness, palpable flank mass (severe/chronic cases, neonates), distended suprapubic bladder (lower tract obstruction), signs of uremia if bilateral
Diagnostics
Renal ultrasound: dilated pelvis and calyces; elevated BUN/creatinine (bilateral or solitary kidney); non-contrast CT to localize the obstructing lesion
Management
Relieve obstruction first: Foley catheter (bladder outlet), ureteral stent or percutaneous nephrostomy (upper tract); treat underlying cause; monitor for post-obstructive diuresis
Keywords
"Dilated collecting system," "post-renal AKI," "backup of urine," "CVA tenderness with rising creatinine," "bilateral hydronephrosis with anuria," "UPJ obstruction in newborn"
01Pathophysiology
Hydronephrosis is not a primary disease. It is a structural consequence of urinary tract obstruction. The core concept is straightforward: when urine cannot drain, pressure builds behind the blockage, and the collecting system dilates.
Under normal physiology, urine flows from the renal tubules into the calyces, through the renal pelvis, down the ureter via peristalsis, into the bladder, and out the urethra. When any segment of this pathway is blocked, pressure rises proximal to the obstruction. This is the retrograde pressure transmission principle. The renal pelvis and calyces, being compliant structures, distend in response.
The critical pathophysiologic link to understand is what this pressure does to the kidney itself. The net filtration pressure at the glomerulus equals the hydrostatic pressure in the glomerular capillary minus the sum of oncotic pressure and Bowman's capsule pressure:
When outflow is obstructed, the back-pressure raises (Bowman's capsule pressure), which directly reduces net filtration pressure and lowers GFR. This is why bilateral hydronephrosis (or hydronephrosis in a solitary kidney) causes post-renal AKI with rising creatinine. Unilateral obstruction, by contrast, typically does not raise creatinine because the contralateral kidney compensates fully.
Beyond the hemodynamic effects, sustained elevated pressure compresses the renal medulla first, then the cortex. The medullary structures (loops of Henle, collecting ducts, vasa recta) are damaged early, which destroys the medullary concentration gradient. This explains a finding that often surprises students: patients with chronic bilateral obstruction may actually present with polyuria and dilute urine rather than oliguria. The kidneys lose their concentrating ability before they lose overall filtration.
Prolonged obstruction triggers tubular atrophy, interstitial fibrosis, and irreversible nephron loss. The general clinical teaching is that obstruction persisting beyond 12 to 14 days carries a substantially higher risk of permanent damage, though partial recovery can occur even after longer durations if decompression is performed.
When obstruction coexists with infection, the stagnant urine creates an ideal bacterial growth medium. This condition, known as pyonephrosis (infected hydronephrosis), is a urologic emergency. The obstructed, infected kidney behaves as a closed-space abscess. Antibiotics cannot adequately penetrate, and drainage is mandatory. This concept is tested frequently.
02Classification and Clinical Manifestation
Classification by Level of Obstruction
Renal pelvis / Ureteropelvic junction (UPJ)
Common Causes
UPJ obstruction (most common congenital cause), renal calculi, blood clots, papillary necrosis fragments
Typical Laterality
Unilateral
Ureter
Common Causes
Ureteral calculi (most common overall cause in young adults), ureteral stricture, extrinsic compression (tumor, retroperitoneal fibrosis, gravid uterus)
Typical Laterality
Unilateral or bilateral
Bladder
Common Causes
Neurogenic bladder, bladder carcinoma, bladder calculi
Typical Laterality
Bilateral
Urethra / Bladder outlet
Common Causes
BPH (most common cause in older males), urethral stricture, posterior urethral valves (most common cause of bilateral hydronephrosis in male neonates)
Typical Laterality
Bilateral
Level | Common Causes | Typical Laterality |
|---|---|---|
Renal pelvis / Ureteropelvic junction (UPJ) | UPJ obstruction (most common congenital cause), renal calculi, blood clots, papillary necrosis fragments | Unilateral |
Ureter | Ureteral calculi (most common overall cause in young adults), ureteral stricture, extrinsic compression (tumor, retroperitoneal fibrosis, gravid uterus) | Unilateral or bilateral |
Bladder | Neurogenic bladder, bladder carcinoma, bladder calculi | Bilateral |
Urethra / Bladder outlet | BPH (most common cause in older males), urethral stricture, posterior urethral valves (most common cause of bilateral hydronephrosis in male neonates) | Bilateral |
Grading by Severity (Society for Fetal Urology Ultrasound Grading)
Grade 0
Ultrasound Appearance
No dilation
Clinical Significance
Normal
Grade I (Mild)
Ultrasound Appearance
Renal pelvis mildly dilated only; calyces not affected
Clinical Significance
Often physiologic (especially in pregnancy); usually observation
Grade II (Mild to Moderate)
Ultrasound Appearance
Pelvis dilated with extension into major calyces
Clinical Significance
Warrants further workup for a cause
Grade III (Moderate)
Ultrasound Appearance
Pelvis and all calyces uniformly dilated; parenchyma preserved
Clinical Significance
Likely obstructive; evaluate for intervention
Grade IV (Severe)
Ultrasound Appearance
All calyces ballooned with thinning of renal parenchyma
Clinical Significance
High risk of irreversible damage; urgent decompression typically required
Grade | Ultrasound Appearance | Clinical Significance |
|---|---|---|
Grade 0 | No dilation | Normal |
Grade I (Mild) | Renal pelvis mildly dilated only; calyces not affected | Often physiologic (especially in pregnancy); usually observation |
Grade II (Mild to Moderate) | Pelvis dilated with extension into major calyces | Warrants further workup for a cause |
Grade III (Moderate) | Pelvis and all calyces uniformly dilated; parenchyma preserved | Likely obstructive; evaluate for intervention |
Grade IV (Severe) | All calyces ballooned with thinning of renal parenchyma | High risk of irreversible damage; urgent decompression typically required |
Clinical Manifestation by Acuity
Pain
Acute Obstruction
Severe colicky flank pain radiating to the groin (classic renal colic)
Chronic Obstruction
Dull, vague flank ache or completely painless
Urine output
Acute Obstruction
Sudden oliguria or anuria (bilateral)
Chronic Obstruction
Paradoxical polyuria (loss of concentrating ability), nocturia
Systemic signs
Acute Obstruction
Nausea, vomiting, diaphoresis
Chronic Obstruction
Hypertension (renin-angiotensin activation), progressive CKD features
Infection signs
Acute Obstruction
Fever, rigors, sepsis if pyonephrosis develops
Chronic Obstruction
Recurrent UTIs
Renal function
Acute Obstruction
Acute creatinine elevation (bilateral)
Chronic Obstruction
Gradual, insidious decline; may present as unexplained CKD
Physical exam
Acute Obstruction
Marked CVA tenderness
Chronic Obstruction
Palpable flank mass possible; may have no focal findings
Feature | Acute Obstruction | Chronic Obstruction |
|---|---|---|
Pain | Severe colicky flank pain radiating to the groin (classic renal colic) | Dull, vague flank ache or completely painless |
Urine output | Sudden oliguria or anuria (bilateral) | Paradoxical polyuria (loss of concentrating ability), nocturia |
Systemic signs | Nausea, vomiting, diaphoresis | Hypertension (renin-angiotensin activation), progressive CKD features |
Infection signs | Fever, rigors, sepsis if pyonephrosis develops | Recurrent UTIs |
Renal function | Acute creatinine elevation (bilateral) | Gradual, insidious decline; may present as unexplained CKD |
Physical exam | Marked CVA tenderness | Palpable flank mass possible; may have no focal findings |
03Diagnostic Workup
Renal Ultrasound
Role
Best initial test
Key Findings
Dilated renal pelvis/calyces; assess parenchymal thickness; evaluate bladder distension
Non-contrast CT Abdomen/Pelvis
Role
Best test to identify the obstructing lesion (especially calculi)
Key Findings
Location, size, and nature of obstruction; perinephric stranding; sensitivity >95% for stones
BUN / Creatinine
Role
Assess functional impact on kidneys
Key Findings
Elevated in bilateral obstruction or solitary kidney
Urinalysis + Culture
Role
Screen for infection and hematuria
Key Findings
Pyuria/bacteriuria indicate infected system; hematuria suggests stones
CBC
Role
Evaluate for systemic infection
Key Findings
Leukocytosis with left shift in pyonephrosis
Basic Metabolic Panel
Role
Monitor electrolytes
Key Findings
Hyperkalemia, non-anion-gap metabolic acidosis (type IV RTA pattern)
Post-void Residual (PVR)
Role
Assess for bladder outlet obstruction
Key Findings
PVR >200 mL indicates incomplete emptying
Diuretic Renography (MAG3 scan)
Role
Confirmatory test for functional obstruction (especially UPJ obstruction)
Key Findings
Plateau or rising curve after furosemide = true obstruction; prompt washout = non-obstructive dilation
VCUG
Role
Evaluate vesicoureteral reflux, posterior urethral valves
Key Findings
Contrast refluxing into ureters; dilated posterior urethra in PUV
Test | Role | Key Findings |
|---|---|---|
Renal Ultrasound | Best initial test | Dilated renal pelvis/calyces; assess parenchymal thickness; evaluate bladder distension |
Non-contrast CT Abdomen/Pelvis | Best test to identify the obstructing lesion (especially calculi) | Location, size, and nature of obstruction; perinephric stranding; sensitivity >95% for stones |
BUN / Creatinine | Assess functional impact on kidneys | Elevated in bilateral obstruction or solitary kidney |
Urinalysis + Culture | Screen for infection and hematuria | Pyuria/bacteriuria indicate infected system; hematuria suggests stones |
CBC | Evaluate for systemic infection | Leukocytosis with left shift in pyonephrosis |
Basic Metabolic Panel | Monitor electrolytes | Hyperkalemia, non-anion-gap metabolic acidosis (type IV RTA pattern) |
Post-void Residual (PVR) | Assess for bladder outlet obstruction | PVR >200 mL indicates incomplete emptying |
Diuretic Renography (MAG3 scan) | Confirmatory test for functional obstruction (especially UPJ obstruction) | Plateau or rising curve after furosemide = true obstruction; prompt washout = non-obstructive dilation |
VCUG | Evaluate vesicoureteral reflux, posterior urethral valves | Contrast refluxing into ureters; dilated posterior urethra in PUV |
The best initial test for suspected hydronephrosis is a renal ultrasound. It is noninvasive, requires no radiation, is inexpensive, and has high sensitivity for detecting collecting system dilation. Ultrasound answers the single most important initial question: is the collecting system dilated or not? It also provides information about parenchymal thickness, which helps distinguish acute from chronic obstruction. In pregnancy, ultrasound is the unquestioned first-line modality.
The main limitation of ultrasound is that it shows you the consequence (dilation) without reliably showing you the cause. The mid-ureter is notoriously difficult to visualize due to overlying bowel gas. For this reason, non-contrast CT of the abdomen and pelvis is the next step when the cause must be identified, particularly when nephrolithiasis is suspected. Non-contrast CT has greater than 95% sensitivity and nearly 100% sensitivity for ureteral stones and is excellent at demonstrating the level of obstruction, secondary signs of acute obstruction (perinephric fat stranding, periureteral edema), and alternative pathology such as tumors or retroperitoneal fibrosis. The reason contrast is withheld initially is twofold: IV contrast can obscure radiopaque stones and carries nephrotoxicity risk in a patient whose renal function may already be compromised.
Laboratory evaluation is essential to assess functional impact. BUN and creatinine establish whether renal function is compromised. If creatinine is elevated in the setting of bilateral hydronephrosis, the diagnosis is post-renal AKI, and the urgency of decompression increases. Electrolytes should be checked because obstructive uropathy damages distal tubular function, impairing potassium and acid secretion, producing a type IV RTA pattern (hyperkalemia with non-anion-gap metabolic acidosis).
Urinalysis and urine culture are non-negotiable. The combination of hydronephrosis, fever, and pyuria points toward pyonephrosis, which changes the management algorithm from "urgent" to "emergent." This is a point where exam questions test whether you recognize the need for drainage over antibiotics alone.
For cases where the clinical question is whether dilation represents true obstruction or simply a floppy, non-obstructed system (common in congenital anomalies and prenatal findings), diuretic renography (MAG3 scan with furosemide) is the confirmatory functional test. A radiotracer is injected, and its clearance from the kidney is measured. Furosemide is then administered. If the tracer washes out briskly, the system is not truly obstructed. If the tracer shows a plateau or rising curve, functional obstruction is confirmed. This test is particularly important in the workup of UPJ obstruction in children, where the decision to proceed with pyeloplasty rests on demonstrating functional compromise.
04Management & Treatment
Bladder outlet obstruction
Intervention
Foley catheter
Details
Immediate decompression; monitor for post-obstructive diuresis
Upper tract obstruction, stable patient
Intervention
Ureteral stent (double-J)
Details
Placed cystoscopically; bypasses the point of obstruction
Upper tract obstruction, stent not feasible
Intervention
Percutaneous nephrostomy (PCN)
Details
IR-guided tube directly into the renal pelvis
Infected hydronephrosis / Pyonephrosis
Intervention
Emergent drainage (PCN or stent) + IV antibiotics
Details
Drainage is the priority; antibiotics alone will fail
Obstructing ureteral stone < 10 mm
Intervention
Medical expulsive therapy
Details
Tamsulosin 0.4 mg PO daily + analgesics; observe for 4 to 6 weeks
Obstructing stone > 10 mm or failed passage
Intervention
Surgical stone removal
Details
Ureteroscopy with laser lithotripsy, shock wave lithotripsy (SWL), or PCNL for large renal stones
BPH causing chronic obstruction
Intervention
Alpha-blocker + 5-alpha-reductase inhibitor
Details
Tamsulosin 0.4 mg daily + finasteride 5 mg daily; TURP if refractory
UPJ obstruction
Intervention
Pyeloplasty
Details
Surgical reconstruction of the UPJ; definitive treatment
Malignant obstruction
Intervention
Stent or PCN + treat the malignancy
Details
Stents may need periodic exchange
Post-obstructive diuresis
Intervention
Fluid replacement + electrolyte monitoring
Details
Replace 50 to 75% of urine output with NS; check lytes every 6 to 12 hours
Clinical Scenario | Intervention | Details |
|---|---|---|
Bladder outlet obstruction | Foley catheter | Immediate decompression; monitor for post-obstructive diuresis |
Upper tract obstruction, stable patient | Ureteral stent (double-J) | Placed cystoscopically; bypasses the point of obstruction |
Upper tract obstruction, stent not feasible | Percutaneous nephrostomy (PCN) | IR-guided tube directly into the renal pelvis |
Infected hydronephrosis / Pyonephrosis | Emergent drainage (PCN or stent) + IV antibiotics | Drainage is the priority; antibiotics alone will fail |
Obstructing ureteral stone < 10 mm | Medical expulsive therapy | Tamsulosin 0.4 mg PO daily + analgesics; observe for 4 to 6 weeks |
Obstructing stone > 10 mm or failed passage | Surgical stone removal | Ureteroscopy with laser lithotripsy, shock wave lithotripsy (SWL), or PCNL for large renal stones |
BPH causing chronic obstruction | Alpha-blocker + 5-alpha-reductase inhibitor | Tamsulosin 0.4 mg daily + finasteride 5 mg daily; TURP if refractory |
UPJ obstruction | Pyeloplasty | Surgical reconstruction of the UPJ; definitive treatment |
Malignant obstruction | Stent or PCN + treat the malignancy | Stents may need periodic exchange |
Post-obstructive diuresis | Fluid replacement + electrolyte monitoring | Replace 50 to 75% of urine output with NS; check lytes every 6 to 12 hours |
Step 1: Decompress the obstructed system. This is the "next best step" in virtually every exam question involving hydronephrosis with compromised renal function. The instinct being tested is: relieve the obstruction first, investigate the cause second. For lower tract obstruction (e.g., BPH, urethral stricture), the immediate intervention is a Foley catheter. For upper tract obstruction where a catheter will not help, the choice is between a retrograde ureteral stent (placed by urology via cystoscopy) or an antegrade percutaneous nephrostomy (placed by interventional radiology). The choice between these depends on clinical context, operator availability, and patient anatomy.
Step 2: Address infection with drainage, not just antibiotics. If fever, pyuria, and a positive culture accompany hydronephrosis, you are dealing with pyonephrosis. Start broad-spectrum IV antibiotics immediately (piperacillin-tazobactam 3.375 g IV every 6 hours, or meropenem 1 g IV every 8 hours if resistant organisms are suspected). However, the non-negotiable teaching point is that antibiotics without drainage will fail. The obstructed infected kidney functions as a walled-off collection that antibiotics cannot adequately penetrate. Emergent drainage via nephrostomy or stent is required. This is a frequently tested "next best step" question where students choose antibiotics alone and get it wrong.
Step 3: Treat the underlying cause. Once acute decompression is achieved, definitive management targets the root pathology:
For nephrolithiasis, stones smaller than 10 mm in the distal ureter have a reasonable chance of spontaneous passage. Medical expulsive therapy with tamsulosin 0.4 mg orally once daily (an alpha-1 blocker that relaxes ureteral smooth muscle) is given alongside adequate analgesia (ketorolac 15 to 30 mg IV, or ibuprofen 400 to 600 mg PO every 6 to 8 hours). If the stone has not passed in 4 to 6 weeks, or if it is larger than 10 mm, or if the patient develops infection, intractable pain, or worsening renal function, surgical intervention is indicated. Options include ureteroscopy with laser lithotripsy (preferred for mid and distal ureteral stones), shock wave lithotripsy (preferred for proximal ureteral or renal stones < 2 cm), and percutaneous nephrolithotomy (for renal stones > 2 cm or staghorn calculi).
For BPH, long-term medical therapy combines an alpha-blocker (tamsulosin 0.4 mg daily) with a 5-alpha-reductase inhibitor (finasteride 5 mg daily). Finasteride reduces prostate volume over 6 to 12 months by blocking the conversion of testosterone to dihydrotestosterone. If medical therapy fails or the patient develops refractory urinary retention, recurrent UTIs, or persistent hydronephrosis, TURP (transurethral resection of the prostate) is the surgical standard.
For UPJ obstruction, the definitive treatment is pyeloplasty, a surgical reconstruction that excises the obstructed segment and re-anastomoses the ureter to the renal pelvis. In pediatric patients, the decision to operate is guided by diuretic renography results (demonstrating functional obstruction and differential renal function).
Step 4: Manage post-obstructive diuresis. This is a critical and frequently tested complication. After decompression of chronic bilateral obstruction, patients often produce enormous volumes of urine (sometimes exceeding 500 mL/hour). The mechanism involves multiple factors: accumulated urea acts as an osmotic diuretic, the damaged medullary interstitium cannot concentrate urine, and volume overload from the period of obstruction is being corrected. The danger lies in rapid volume depletion, hyponatremia, and hypokalemia if the diuresis is not managed carefully.
The correct approach is to replace approximately 50 to 75% of hourly urine output with intravenous normal saline. Matching output milliliter-for-milliliter is a trap answer because it perpetuates the diuresis by maintaining the volume stimulus. Electrolytes (particularly potassium and sodium) should be checked every 6 to 12 hours. The diuresis typically resolves within 24 to 48 hours as renal function stabilizes.
Contraindications and Special Populations: In pregnancy, imaging should be limited to ultrasound. MRI without gadolinium is an acceptable second-line modality. CT is avoided unless no other option exists. Physiologic hydronephrosis of pregnancy (predominantly right-sided due to uterine dextrorotation and compression by the right ovarian vein) must be differentiated from pathologic obstruction. For intervention, ureteral stenting is generally preferred over nephrostomy when feasible.
In patients with coagulopathy, percutaneous nephrostomy carries increased bleeding risk. Correct coagulopathy before the procedure or opt for retrograde stenting if possible.
05Differential Diagnosis & Distractors
Physiologic hydronephrosis of pregnancy
Why It Is Similar
Bilateral (right-predominant) dilation of the collecting system during second/third trimester
Key Discriminator
No pain, no elevated creatinine, resolves postpartum; right side more affected; no identifiable obstructing lesion
Simple renal cyst
Why It Is Similar
Both appear as fluid-filled structures on ultrasound
Key Discriminator
A cyst is a discrete, round, anechoic structure that does not communicate with the collecting system; hydronephrosis shows a branching pelvicalyceal dilation pattern
Parapelvic cyst
Why It Is Similar
Located at the renal hilum; can closely mimic a dilated renal pelvis
Key Discriminator
Does not connect with the collecting system on CT urography or contrast-enhanced studies
Vesicoureteral reflux (VUR)
Why It Is Similar
Can cause bilateral hydroureteronephrosis, especially in pediatric patients
Key Discriminator
Dilation is caused by retrograde urine flow, not antegrade obstruction; diagnosed by VCUG showing contrast refluxing upward during voiding
Acute pyelonephritis
Why It Is Similar
Both present with flank pain, fever, and CVA tenderness
Key Discriminator
Pyelonephritis does not cause collecting system dilation unless concurrent obstruction exists; urinalysis shows WBC casts; imaging shows renal parenchymal inflammation without pelvic dilation
Renal cell carcinoma
Why It Is Similar
Can cause hydronephrosis if the tumor obstructs the pelvis or ureter
Key Discriminator
Imaging reveals a solid, enhancing renal mass; hematuria is painless and often gross; constitutional symptoms (weight loss, night sweats) may be present
Retroperitoneal fibrosis
Why It Is Similar
Causes bilateral hydronephrosis by encasing the ureters
Key Discriminator
CT demonstrates a fibrotic soft-tissue mass surrounding the aorta at L4-L5; ureters are characteristically pulled medially (not displaced laterally)
Multicystic dysplastic kidney (MCDK)
Why It Is Similar
In neonates, both present as a large, cystic renal mass on prenatal or postnatal ultrasound
Key Discriminator
MCDK shows multiple non-communicating cysts of varying sizes with no identifiable renal pelvis; hydronephrosis shows a central dilated pelvis communicating with dilated calyces
Differential | Why It Is Similar | Key Discriminator |
|---|---|---|
Physiologic hydronephrosis of pregnancy | Bilateral (right-predominant) dilation of the collecting system during second/third trimester | No pain, no elevated creatinine, resolves postpartum; right side more affected; no identifiable obstructing lesion |
Simple renal cyst | Both appear as fluid-filled structures on ultrasound | A cyst is a discrete, round, anechoic structure that does not communicate with the collecting system; hydronephrosis shows a branching pelvicalyceal dilation pattern |
Parapelvic cyst | Located at the renal hilum; can closely mimic a dilated renal pelvis | Does not connect with the collecting system on CT urography or contrast-enhanced studies |
Vesicoureteral reflux (VUR) | Can cause bilateral hydroureteronephrosis, especially in pediatric patients | Dilation is caused by retrograde urine flow, not antegrade obstruction; diagnosed by VCUG showing contrast refluxing upward during voiding |
Acute pyelonephritis | Both present with flank pain, fever, and CVA tenderness | Pyelonephritis does not cause collecting system dilation unless concurrent obstruction exists; urinalysis shows WBC casts; imaging shows renal parenchymal inflammation without pelvic dilation |
Renal cell carcinoma | Can cause hydronephrosis if the tumor obstructs the pelvis or ureter | Imaging reveals a solid, enhancing renal mass; hematuria is painless and often gross; constitutional symptoms (weight loss, night sweats) may be present |
Retroperitoneal fibrosis | Causes bilateral hydronephrosis by encasing the ureters | CT demonstrates a fibrotic soft-tissue mass surrounding the aorta at L4-L5; ureters are characteristically pulled medially (not displaced laterally) |
Multicystic dysplastic kidney (MCDK) | In neonates, both present as a large, cystic renal mass on prenatal or postnatal ultrasound | MCDK shows multiple non-communicating cysts of varying sizes with no identifiable renal pelvis; hydronephrosis shows a central dilated pelvis communicating with dilated calyces |
06Traps & High-Yield Pearls
The most common trap involving hydronephrosis on licensing exams is failing to identify post-renal obstruction as the cause of acute kidney injury. When a vignette presents rising creatinine with oliguria or anuria, students often focus on intrinsic renal etiologies (ATN, glomerulonephritis) and order tests like renal biopsy or urine eosinophils. The correct first step is a renal ultrasound to rule out obstruction. Post-renal AKI is the most readily reversible cause of kidney injury, and the exam rewards the student who thinks of it first.
The second classic trap is the pyonephrosis management question. The vignette will describe a patient with hydronephrosis, fever, and pyuria. The distractors will include "start IV antibiotics and reassess in 48 hours." This answer is wrong. Antibiotics alone cannot treat a closed infected space. The answer is always emergent drainage plus antibiotics. If you remember only one thing about infected hydronephrosis, remember that drainage is non-negotiable.
Third, beware of pregnancy-related confusion. A mild right-sided hydronephrosis found incidentally in a 28-week pregnant woman with no symptoms and normal creatinine is almost certainly physiologic. Do not order CT. Do not recommend stenting. The answer is observation.
Fourth, the post-obstructive diuresis question is a classic trap. After relief of chronic bilateral obstruction, the patient makes enormous amounts of dilute urine. The wrong answer is to match output 1:1 with IV fluids. The correct approach is to replace 50 to 75% of output with normal saline and check electrolytes every 6 to 12 hours. Matching output fully perpetuates the diuresis, while ignoring it entirely risks hypovolemic shock.
Finally, students sometimes confuse hydronephrosis with a parapelvic cyst or a multicystic dysplastic kidney. The key is communication: in hydronephrosis, the dilated calyces connect with a dilated pelvis in a recognizable branching pattern. In cystic conditions, the fluid collections are isolated and do not interconnect. This distinction is often presented as an ultrasound image interpretation question.
The core competency being assessed across all hydronephrosis questions is the ability to recognize obstruction as a cause of renal dysfunction, image it correctly, decompress it urgently, and manage the physiologic consequences of relief.